Long-term respiratory consequences of premature birth at less than 32 weeks of gestation

Anne Greenough1

  • 1Division of Asthma, Allergy and Lung Biology, The MRC & Asthma UK Centre in Allergic Mechanisms of Asthma King's College, London, UK.

Insights

Very premature infants, especially those with bronchopulmonary dysplasia (BPD), often face chronic respiratory issues and increased healthcare needs. Lung function may improve with age, but persistent airflow limitation and potential deterioration require further study.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Respiratory Medicine

Background:

  • Chronic respiratory morbidity is a significant adverse outcome for very premature infants.
  • Bronchopulmonary dysplasia (BPD) is a common complication, leading to prolonged oxygen dependence and increased healthcare utilization.
  • Chest imaging, including CT scans, provides predictive information for respiratory problems in these children.

Purpose of the Study:

  • To review the chronic respiratory outcomes in very premature infants, with a focus on those who developed BPD.
  • To highlight the impact of respiratory syncytial virus lower respiratory infections (RSV LRTIs) on BPD patients.
  • To discuss the trajectory of pulmonary function and the need for longitudinal studies.

Main Methods:

  • Review of existing literature on chronic respiratory morbidity in premature infants.
  • Analysis of data regarding healthcare utilization, hospital readmissions, and respiratory symptoms.
  • Evaluation of chest imaging findings and pulmonary function tests.

Main Results:

  • Infants with BPD often require long-term home oxygen and have increased healthcare needs until school age.
  • Hospital readmissions are frequent, especially for BPD infants experiencing RSV LRTIs.
  • Recurrent respiratory symptoms, airway obstruction, and gas trapping are common, with airflow limitation persisting despite age-related improvements.

Conclusions:

  • Children with BPD face significant, long-term respiratory challenges, including persistent airflow limitation.
  • RSV LRTIs can exacerbate lung function abnormalities in infants with BPD.
  • Longitudinal research is essential to understand lung function development and potential catch-up growth in this population.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...